• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过免疫印迹法测定的VIII因子抑制剂IgG亚类和VIII因子多肽特异性。

FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting.

作者信息

Fulcher C A, de Graaf Mahoney S, Zimmerman T S

出版信息

Blood. 1987 May;69(5):1475-80.

PMID:2436689
Abstract

We used immunoblotting of purified factor VIII coagulant protein (FVIII) to localize FVIII inhibitor epitopes in 76 inhibitor plasmas to either the 92-kd FVIII polypeptide (and its 54-kd and/or 44-kd thrombin fragments), the 80-kd polypeptide (and its 72-kd thrombin fragment), or both of these polypeptides. We also used immunoblotting to examine the immunoglobulin class and subclass content of 12 inhibitors with monoclonal antibodies specific for human IgG subclasses and IgM. Seven hemophilic (alloantibody) and five spontaneous (autoantibody) inhibitors contained IgG-1 and IgG-4 antibody; one of the spontaneous inhibitors also contained IgG-3. In one hemophilic inhibitor, the IgG-4 component reacted strongly with the 92-kd and 80-kd polypeptides, whereas the IgG-1 component reacted only minimally with the 92-kd polypeptide although its reactivity with the 80-kd polypeptide was strong. Another hemophilic inhibitor was affinity purified and subjected to quantitative radial immunodiffusion, and the presence of IgG-1 and IgG-4 antibody was confirmed. We conclude that the inhibitors examined are not monoclonal but are probably of restricted polyclonal origin and that different IgG subclasses in an inhibitor plasma can have different degrees of FVIII polypeptide reactivity.

摘要

我们采用纯化的凝血因子VIII(FVIII)蛋白进行免疫印迹,将76份含有FVIII抑制物的血浆中的FVIII抑制表位定位到92-kd FVIII多肽(及其54-kd和/或44-kd凝血酶片段)、80-kd多肽(及其72-kd凝血酶片段)或这两种多肽上。我们还使用免疫印迹法,用针对人IgG亚类和IgM的单克隆抗体检测了12份抑制物的免疫球蛋白类别和亚类含量。7份血友病(同种抗体)抑制物和5份自发性(自身抗体)抑制物含有IgG-1和IgG-4抗体;其中1份自发性抑制物还含有IgG-3。在1份血友病抑制物中,IgG-4成分与92-kd和80-kd多肽强烈反应,而IgG-1成分与92-kd多肽反应微弱,尽管其与80-kd多肽反应强烈。另一份血友病抑制物经亲和纯化后进行定量放射免疫扩散,证实存在IgG-1和IgG-4抗体。我们得出结论,所检测的抑制物不是单克隆的,可能起源于有限的多克隆,并且抑制物血浆中的不同IgG亚类对FVIII多肽的反应程度可能不同。

相似文献

1
FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting.通过免疫印迹法测定的VIII因子抑制剂IgG亚类和VIII因子多肽特异性。
Blood. 1987 May;69(5):1475-80.
2
Immunoblot analysis shows changes in factor VIII inhibitor chain specificity in factor VIII inhibitor patients over time.免疫印迹分析显示,随着时间推移,血友病甲抑制物患者体内的凝血因子VIII抑制物链特异性发生了变化。
Blood. 1988 Oct;72(4):1348-56.
3
Localization of human factor FVIII inhibitor epitopes to two polypeptide fragments.人凝血因子FVIII抑制剂表位定位于两个多肽片段。
Proc Natl Acad Sci U S A. 1985 Nov;82(22):7728-32. doi: 10.1073/pnas.82.22.7728.
4
Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site.一些凝血因子VIII抑制物抗体识别一个与C2结构域氨基酸2248至2312相对应的共同表位,该表位与一个磷脂结合位点重叠。
Blood. 1995 Sep 1;86(5):1811-9.
5
Epitope mapping of human factor VIII inhibitor antibodies by site-directed mutagenesis of a factor VIII polypeptide.
Blood Coagul Fibrinolysis. 1992 Dec;3(6):703-16. doi: 10.1097/00001721-199212000-00002.
6
Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization.通过免疫印迹和抗体中和法对人凝血因子VIII抑制物抗体的表位进行定位
Blood. 1989 Oct;74(5):1618-26.
7
In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic.在甲型血友病和自身抗体抑制剂患者中:凝血因子VIII A2结构域和轻链具有最强的免疫原性。
Thromb Res. 2001 Mar 1;101(5):377-85. doi: 10.1016/s0049-3848(00)00418-7.
8
[Identification of IgG subclass and FVIII binding epitope of an acquired FVIII inhibitor in a bullous pemphigoid patient].[大疱性类天疱疮患者获得性FVIII抑制剂的IgG亚类及FVIII结合表位鉴定]
Zhonghua Xue Ye Xue Za Zhi. 2006 Sep;27(9):593-7.
9
Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity are present in plasma of nonresponder patients with severe hemophilia A and in normal polyclonal human IgG.中和FVIII促凝血活性的抗FVIII轻链抗体存在于重度A型血友病无反应患者的血浆以及正常多克隆人IgG中。
Blood. 2000 Jun 1;95(11):3435-41.
10
A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients.一项针对抗FVIII抗体的纵向评估表明,IgG4亚类主要与A型血友病患者的高滴度抑制物相关。
Haemophilia. 2015 Sep;21(5):686-92. doi: 10.1111/hae.12646. Epub 2015 Feb 24.

引用本文的文献

1
Systemic lupus erythematosus with acquired hemophilia A: A case report and literature review.系统性红斑狼疮合并获得性血友病 A:病例报告及文献复习。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 May 28;48(5):789-794. doi: 10.11817/j.issn.1672-7347.2023.220440.
2
Acquired Haemophilia A: A Review of What We Know.获得性血友病A:我们所了解的综述。
J Blood Med. 2022 Nov 23;13:691-710. doi: 10.2147/JBM.S342077. eCollection 2022.
3
Acquired Hemophilia A in IgG4-Related Disease: Case Report, Immunopathogenic Study, and Review of the Literature.
获得性血友病 A 合并 IgG4 相关疾病:病例报告、免疫发病机制研究及文献复习。
Front Immunol. 2020 Dec 18;11:558811. doi: 10.3389/fimmu.2020.558811. eCollection 2020.
4
In Silico Study of Correlation between Missense Variations of Gene and Inhibitor Formation in Severe Hemophilia A.严重血友病 A 基因错义变异与抑制剂形成的计算机研究
Turk J Haematol. 2020 May 6;37(2):77-83. doi: 10.4274/tjh.galenos.2019.2019.0094. Epub 2019 Dec 26.
5
Acquired hemophilia A associated with autoimmune pancreatitis with serum IgG4 elevation.获得性血友病A合并自身免疫性胰腺炎伴血清IgG4升高。
Int J Hematol. 2018 Sep;108(3):335-338. doi: 10.1007/s12185-018-2441-3. Epub 2018 Mar 26.
6
Effects of pre-analytical heat treatment in factor VIII (FVIII) inhibitor assays on FVIII antibody levels.热预处理对因子 VIII(FVIII)抑制剂检测中 FVIII 抗体水平的影响。
Haemophilia. 2018 May;24(3):487-491. doi: 10.1111/hae.13435. Epub 2018 Feb 20.
7
Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review.实验室检测血友病患者的因子 VIII 和 IX 抑制剂:综述。
Haemophilia. 2018 Mar;24(2):186-197. doi: 10.1111/hae.13424. Epub 2018 Feb 15.
8
Frequency and epitope specificity of anti-factor VIII C1 domain antibodies in acquired and congenital hemophilia A.获得性和先天性血友病A中抗因子VIII C1结构域抗体的频率和表位特异性
Blood. 2017 Aug 10;130(6):808-816. doi: 10.1182/blood-2016-11-751347. Epub 2017 May 15.
9
Approaches to Mitigate the Unwanted Immunogenicity of Therapeutic Proteins during Drug Development.在药物研发过程中减轻治疗性蛋白质不必要免疫原性的方法。
AAPS J. 2017 Mar;19(2):377-385. doi: 10.1208/s12248-016-0030-z. Epub 2017 Jan 12.
10
Six amino acid residues in a 1200 Å2 interface mediate binding of factor VIII to an IgG4κ inhibitory antibody.在一个1200 Ų的界面中的六个氨基酸残基介导了凝血因子VIII与一种IgG4κ抑制性抗体的结合。
PLoS One. 2015 Jan 23;10(1):e0116577. doi: 10.1371/journal.pone.0116577. eCollection 2015.